CCCC
Price
$1.73
Change
+$0.26 (+17.69%)
Updated
Jun 6 closing price
Capitalization
104.03M
59 days until earnings call
CELC
Price
$13.05
Change
+$1.27 (+10.78%)
Updated
Jun 6 closing price
Capitalization
446.82M
60 days until earnings call
Interact to see
Advertisement

CCCC vs CELC

Header iconCCCC vs CELC Comparison
Open Charts CCCC vs CELCBanner chart's image
C4 Therapeutics
Price$1.73
Change+$0.26 (+17.69%)
Volume$1.28M
Capitalization104.03M
Celcuity
Price$13.05
Change+$1.27 (+10.78%)
Volume$188.2K
Capitalization446.82M
CCCC vs CELC Comparison Chart
Loading...
CCCC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CELC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CCCC vs. CELC commentary
Jun 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CCCC is a Buy and CELC is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 08, 2025
Stock price -- (CCCC: $1.26 vs. CELC: $10.50)
Brand notoriety: CCCC and CELC are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CCCC: 69% vs. CELC: 38%
Market capitalization -- CCCC: $104.03M vs. CELC: $446.82M
CCCC [@Biotechnology] is valued at $104.03M. CELC’s [@Biotechnology] market capitalization is $446.82M. The market cap for tickers in the [@Biotechnology] industry ranges from $323.27B to $0. The average market capitalization across the [@Biotechnology] industry is $2.25B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CCCC’s FA Score shows that 1 FA rating(s) are green whileCELC’s FA Score has 0 green FA rating(s).

  • CCCC’s FA Score: 1 green, 4 red.
  • CELC’s FA Score: 0 green, 5 red.
According to our system of comparison, CELC is a better buy in the long-term than CCCC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CCCC’s TA Score shows that 3 TA indicator(s) are bullish while CELC’s TA Score has 5 bullish TA indicator(s).

  • CCCC’s TA Score: 3 bullish, 3 bearish.
  • CELC’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, CELC is a better buy in the short-term than CCCC.

Price Growth

CCCC (@Biotechnology) experienced а -7.35% price change this week, while CELC (@Biotechnology) price change was -0.94% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.11%. For the same industry, the average monthly price growth was +10.01%, and the average quarterly price growth was -2.16%.

Reported Earning Dates

CCCC is expected to report earnings on Aug 06, 2025.

CELC is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Biotechnology (+4.11% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CELC($447M) has a higher market cap than CCCC($104M). CELC YTD gains are higher at: -19.786 vs. CCCC (-65.000). CELC has higher annual earnings (EBITDA): -85.45M vs. CCCC (-103.37M). CELC has more cash in the bank: 264M vs. CCCC (245M). CCCC has less debt than CELC: CCCC (65.8M) vs CELC (97.2M). CCCC has higher revenues than CELC: CCCC (35.6M) vs CELC (0).
CCCCCELCCCCC / CELC
Capitalization104M447M23%
EBITDA-103.37M-85.45M121%
Gain YTD-65.000-19.786329%
P/E RatioN/AN/A-
Revenue35.6M0-
Total Cash245M264M93%
Total Debt65.8M97.2M68%
FUNDAMENTALS RATINGS
CELC: Fundamental Ratings
CELC
OUTLOOK RATING
1..100
12
VALUATION
overvalued / fair valued / undervalued
1..100
49
Fair valued
PROFIT vs RISK RATING
1..100
81
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
61
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
49

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CCCCCELC
RSI
ODDS (%)
N/A
N/A
Stochastic
ODDS (%)
Bullish Trend 12 days ago
84%
Bullish Trend 12 days ago
82%
Momentum
ODDS (%)
Bearish Trend 12 days ago
90%
Bearish Trend 12 days ago
90%
MACD
ODDS (%)
Bearish Trend 12 days ago
90%
Bearish Trend 12 days ago
83%
TrendWeek
ODDS (%)
Bearish Trend 12 days ago
89%
Bearish Trend 12 days ago
87%
TrendMonth
ODDS (%)
Bearish Trend 12 days ago
90%
Bearish Trend 12 days ago
85%
Advances
ODDS (%)
Bullish Trend about 1 month ago
82%
Bullish Trend 26 days ago
83%
Declines
ODDS (%)
Bearish Trend 12 days ago
89%
Bearish Trend 19 days ago
87%
BollingerBands
ODDS (%)
N/A
N/A
Aroon
ODDS (%)
Bullish Trend 12 days ago
81%
Bullish Trend 12 days ago
85%
View a ticker or compare two or three
Interact to see
Advertisement
CCCC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CELC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AAPL200.420.21
+0.10%
Apple
SPY587.73-3.42
-0.58%
SPDR® S&P 500® ETF
BTC.X107802.330000-1192.312500
-1.09%
Bitcoin cryptocurrency
TSLA356.90-5.99
-1.65%
Tesla
GME31.21-3.80
-10.85%
GameStop Corp

CCCC and

Correlation & Price change

A.I.dvisor indicates that over the last year, CCCC has been loosely correlated with KYMR. These tickers have moved in lockstep 64% of the time. This A.I.-generated data suggests there is some statistical probability that if CCCC jumps, then KYMR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CCCC
1D Price
Change %
CCCC100%
-3.08%
KYMR - CCCC
64%
Loosely correlated
+2.35%
CRBU - CCCC
53%
Loosely correlated
+2.75%
BEAM - CCCC
53%
Loosely correlated
-0.88%
FATE - CCCC
52%
Loosely correlated
+4.10%
NTLA - CCCC
51%
Loosely correlated
+3.59%
More

CELC and

Correlation & Price change

A.I.dvisor indicates that over the last year, CELC has been loosely correlated with ATXS. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if CELC jumps, then ATXS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CELC
1D Price
Change %
CELC100%
-0.38%
ATXS - CELC
45%
Loosely correlated
+6.85%
CLDX - CELC
44%
Loosely correlated
-5.66%
PRME - CELC
44%
Loosely correlated
N/A
ABOS - CELC
43%
Loosely correlated
N/A
CCCC - CELC
43%
Loosely correlated
-3.08%
More